Cytori Therapeutics reported $-1396000 in Operating Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US $ 250M 220M
Dr.Reddys Laboratories DRRD:IN 2.28B 6.12B
Haemonetics HAE:US $ 40.42M 18.36M
Infinity Pharmaceuticals INFI:US $ -8.85M 0.07M
Mirati Therapeutics MRTX:US $ -106.34M 17.66M
Sun Pharmaceuticals SUNP:IN IR 18025.7M 84.7M
Sunesis Pharmaceuticals SNSS:US $ -4.47M 1.87M
Teva Pharmaceutical TEVA:IT 405M 4.75B